Virtus ETF Advisers’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-4,322
| Closed | -$605K | – | 301 |
|
|
2018
Q4 | $605K | Buy |
4,322
+1,684
| +64% | +$236K | 0.1% | 42 |
|
|
2018
Q3 | $451K | Sell |
2,638
-1,897
| -42% | -$324K | 0.05% | 138 |
|
|
2018
Q2 | $787K | Sell |
4,535
-4,811
| -51% | -$835K | 0.7% | 39 |
|
|
2018
Q1 | $1.08M | Buy |
9,346
+4,922
| +111% | +$568K | 0.94% | 30 |
|
|
2017
Q4 | $372K | Buy |
4,424
+11
| +0.2% | +$925 | 0.47% | 70 |
|
|
2017
Q3 | $407K | Buy |
4,413
+404
| +10% | +$37.3K | 0.05% | 107 |
|
|
2017
Q2 | $321K | Sell |
4,009
-6,399
| -61% | -$512K | 0.05% | 106 |
|
|
2017
Q1 | $438K | Buy |
10,408
+997
| +11% | +$42K | 0.08% | 109 |
|
|
2016
Q4 | $302K | Sell |
9,411
-820
| -8% | -$26.3K | 0.09% | 110 |
|
|
2016
Q3 | $268K | Hold |
10,231
| – | – | 0.13% | 117 |
|
|
2016
Q2 | $237K | Buy |
10,231
+1,519
| +17% | +$35.2K | 0.18% | 107 |
|
|
2016
Q1 | $238K | Sell |
8,712
-546
| -6% | -$14.9K | 0.33% | 66 |
|
|
2015
Q4 | $263K | Buy |
+9,258
| New | +$263K | 0.72% | 55 |
|